Axsome Therapeutics (AXSM) Non-Current Deferred Tax Liability (2019)

Axsome Therapeutics (AXSM) reported Non-Current Deferred Tax Liability of $121875.0 for Q4 2019.

Axsome Therapeutics (AXSM) Non-Current Deferred Tax Liability (2019) Analysis & Trends

Axsome Therapeutics (AXSM) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $121875.0 in Q4 2019.

For the quarter ending Q4 2019, Non-Current Deferred Tax Liability changed N/A year-over-year to $121875.0; the trailing twelve-month figure through Dec 2019 stood at $121875.0 (changed N/A YoY), and the FY2019 full-year result was $121875.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability was little changed at $121875.0 in Q4 2019.
In the past five years, Non-Current Deferred Tax Liability ranged from a high of $121875.0 in Q4 2019 to a low of $121875.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Axsome Therapeutics	12.37 Bn	12.06 Bn	176.48 Mn

Download Data

Date	Value
Dec 31, 2019	121,875.00
Dec 31, 2019	121,875.00